Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

In the Weeds with Emily Willingham on Medical Cannabis

In the Weeds with Emily Willingham on Medical Cannabis

FromPoint of Inquiry


In the Weeds with Emily Willingham on Medical Cannabis

FromPoint of Inquiry

ratings:
Length:
26 minutes
Released:
Sep 7, 2016
Format:
Podcast episode

Description

Emily Willingham is a journalist, scientist, and award winning skeptical blogger, with much of her work centered on autism and debunking junk science controversies. Recently the autism community has shown a surge in support for medical cannabis, as anti-vaccination activists claim that cannabis may hold the key for a cure, and many people with autism claim it to be a useful for controlling their symptoms. Willingham and host Lindsay Beyerstein delve further into the topic to sort through the misconceptions that exist on both sides of the debate. Willingham explains that the data is limited on the relationship between cannabis and autism, in part because of the strict research restrictions that have been placed on what the government classifies as a Schedule I substance, a drug with no medical value. Despite the abundance of data showing its benefits and safety in regard to pain relief and inducing appetite, Willingham points out that the stigma against cannabis has lead to restrictions that are even more severe than those that exist on many other pain killers and opioids.   Emily Willingham will also be speaking at the upcoming Women in Secularism conference, September 23-25 in Arlington, VA. For more information go to womeninsecularism.org.   
Released:
Sep 7, 2016
Format:
Podcast episode

Titles in the series (100)

Launched in 2005, Point of Inquiry is the premier podcast of the Center for Inquiry. Point of Inquiry critically examines topics in science, religion, philosophy, and politics. Each episode takes on a specific issue and features in-depth discussions with leading scientists, researchers, and writers.